• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

止血与血栓形成:概述,重点介绍相关实验室检测,以诊断和帮助管理相关疾病。

Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.

机构信息

School of Medical Sciences, Faculty of Medicine and Health University of Sydney, Westmead Hospital, Westmead, NSW, Australia.

School of Dentistry and Medical Sciences, Faculty of Science and Health, Charles Sturt University, Wagga, Wagga, NSW, Australia.

出版信息

Methods Mol Biol. 2023;2663:3-38. doi: 10.1007/978-1-0716-3175-1_1.

DOI:10.1007/978-1-0716-3175-1_1
PMID:37204701
Abstract

Hemostasis is a complex but balanced process that permit normal blood flow, without adverse events. Disruption of the balance may lead to bleeding or thrombotic events, and clinical interventions may be required. Hemostasis laboratories typically offer an array of tests, including routine coagulation and specialized hemostasis assays used to guide clinicians for diagnosing and managing patients. Routine assays may be used to screen patients for hemostasis-related disturbances but may also be used for drug monitoring, measuring efficacy of replacement or adjunctive therapy, and other indications, which may then be used to guide further patient management. Similarly, "specialized" assays are used for diagnostic purposes or may be used to monitor or measure efficacy of a given therapy. This chapter provides an overview of hemostasis and thrombosis, with a focus on laboratory testing that may be used to diagnose and help manage patients suspected of hemostasis- and thrombosis-related disorders.

摘要

止血是一个复杂但平衡的过程,允许正常的血流而不会产生不良事件。平衡的破坏可能导致出血或血栓形成事件,可能需要临床干预。止血实验室通常提供一系列测试,包括常规凝血和专门的止血测定,用于指导临床医生诊断和治疗患者。常规测定可用于筛查患者的止血相关障碍,也可用于药物监测、评估替代或辅助治疗的效果以及其他适应证,然后可用于指导进一步的患者管理。同样,“专门”的测定用于诊断目的,或用于监测或评估特定治疗的效果。本章概述了止血和血栓形成,重点介绍了可能用于诊断和帮助管理疑似止血和血栓形成相关疾病患者的实验室检测。

相似文献

1
Hemostasis and Thrombosis: An Overview Focusing on Associated Laboratory Testing to Diagnose and Help Manage Related Disorders.止血与血栓形成:概述,重点介绍相关实验室检测,以诊断和帮助管理相关疾病。
Methods Mol Biol. 2023;2663:3-38. doi: 10.1007/978-1-0716-3175-1_1.
2
Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders.止血与血栓形成概述以及实验室检测在止血与血栓形成障碍诊断和管理中的作用
Methods Mol Biol. 2017;1646:3-27. doi: 10.1007/978-1-4939-7196-1_1.
3
Emerging technologies in hemostasis diagnostics: a report from the Australasian Society of Thrombosis and Haemostasis Emerging Technologies Group.止血诊断中的新兴技术:来自澳大利亚和新西兰血栓与止血学会新兴技术小组的报告
Semin Thromb Hemost. 2007 Apr;33(3):226-34. doi: 10.1055/s-2007-971808.
4
Understanding the "philosophy" of laboratory hemostasis.理解实验室止血的“原理”。
Diagnosis (Berl). 2019 Aug 27;6(3):223-226. doi: 10.1515/dx-2018-0099.
5
Preanalytical Issues in Hemostasis and Thrombosis Testing.止血与血栓形成检测中的分析前问题
Methods Mol Biol. 2017;1646:29-42. doi: 10.1007/978-1-4939-7196-1_2.
6
A guide for diagnosis of patients with arterial and venous thrombosis.动静脉血栓形成患者的诊断指南。
Clin Lab Sci. 2000 Fall;13(4):229-38.
7
Laboratory diagnosis of hemorrhagic and thrombotic disorders.出血性和血栓性疾病的实验室诊断
Hematol Oncol Clin North Am. 1994 Aug;8(4):809-53.
8
Preanalytical Variables in Hemostasis Testing.止血检测的分析前变量。
Methods Mol Biol. 2023;2663:39-50. doi: 10.1007/978-1-0716-3175-1_2.
9
Evaluation of Coagulation in the Neurosurgery Patient.神经外科患者凝血功能评估
Neurosurg Clin N Am. 2018 Oct;29(4):485-492. doi: 10.1016/j.nec.2018.06.001.
10
Understanding the delicate balance between bleeding and thrombosis: can we use it to our advantage?了解出血与血栓形成之间的微妙平衡:我们能否加以利用?
J Extra Corpor Technol. 2012 Mar;44(1):P13-5.

引用本文的文献

1
Laboratory Assessment of Factor VIII Inhibitors: When Is It Required? A Perspective Informed by Local Practice.VIII因子抑制剂的实验室评估:何时需要进行?基于当地实践的观点。
J Clin Med. 2024 Dec 24;14(1):13. doi: 10.3390/jcm14010013.
2
A Chromosome-Level Genome Assembly of the Non-Hematophagous Leech (Whitman 1884): Identification and Expression Analysis of Antithrombotic Genes.非吸血蛭(Whitman 1884)染色体水平基因组组装:抗血栓基因的鉴定和表达分析。
Genes (Basel). 2024 Jan 26;15(2):164. doi: 10.3390/genes15020164.
3
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls.

本文引用的文献

1
Harmonizing factor assay-related testing performed in a large laboratory network.在大型实验室网络中进行的协调因子测定相关检测。
Blood Coagul Fibrinolysis. 2022 Oct 1;33(7):402-411. doi: 10.1097/MBC.0000000000001155. Epub 2022 Jul 22.
2
D-dimers-"Normal" Levels versus Elevated Levels Due to a Range of Conditions, Including "D-dimeritis," Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19.D-二聚体——正常水平与因多种情况导致的升高水平,包括“D-二聚体血症”、炎症、血栓栓塞、弥散性血管内凝血和 COVID-19。
Semin Thromb Hemost. 2022 Sep;48(6):672-679. doi: 10.1055/s-0042-1748193. Epub 2022 Jul 8.
3
国际血液学标准化委员会关于凝血试剂、校准品和质控品新批号验证的指南。
Semin Thromb Hemost. 2024 Nov;50(8):1091-1102. doi: 10.1055/s-0043-1776405. Epub 2023 Nov 15.
Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants.
抗凝期间的狼疮抗凝物检测,包括直接口服抗凝剂。
Res Pract Thromb Haemost. 2022 Mar 15;6(2):e12676. doi: 10.1002/rth2.12676. eCollection 2022 Feb.
4
A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network.多实验室评估在 ACL TOP 50 家族上进行的狼疮抗凝物检测,以在大型实验室网络中进行协调检测。
Int J Lab Hematol. 2022 Jun;44(3):654-665. doi: 10.1111/ijlh.13818. Epub 2022 Mar 1.
5
An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor Deficiencies.大型实验室网络中活化部分凝血活酶时间(APTT)检测对凝血因子缺乏症的敏感性分析。
Am J Clin Pathol. 2022 Jul 1;158(1):132-141. doi: 10.1093/ajcp/aqac013.
6
Laboratory testing for platelet factor 4 antibodies: differential utility for diagnosis/exclusion of heparin induced thrombocytopenia versus suspected vaccine induced thrombotic thrombocytopenia.血小板因子 4 抗体的实验室检测:在诊断/排除肝素诱导的血小板减少症与疑似疫苗诱导的血栓性血小板减少症方面的不同效用。
Pathology. 2022 Apr;54(3):254-261. doi: 10.1016/j.pathol.2021.10.008. Epub 2022 Feb 4.
7
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan.自身免疫性获得性因子 V 缺乏症凝血异常的综述——重点关注日本。
Semin Thromb Hemost. 2022 Mar;48(2):206-218. doi: 10.1055/s-0041-1740149. Epub 2021 Dec 23.
8
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assays.评估使用当代血管性血友病因子检测方法对血管性血友病进行实验室鉴定时的误差。
Pathology. 2022 Apr;54(3):308-317. doi: 10.1016/j.pathol.2021.07.001. Epub 2021 Sep 20.
9
Why is Misdiagnosis of von Willebrand Disease Still Prevalent and How Can We Overcome It? A Focus on Clinical Considerations and Recommendations.血管性血友病的误诊为何仍然普遍,我们如何克服这一问题?聚焦临床考量与建议。
J Blood Med. 2021 Aug 17;12:755-768. doi: 10.2147/JBM.S266791. eCollection 2021.
10
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches.癌症合并冠状动脉疾病患者的单药、双联及三联抗血栓治疗:探寻证据和个体化方法。
Semin Thromb Hemost. 2021 Nov;47(8):950-961. doi: 10.1055/s-0041-1726298. Epub 2021 Jul 14.